Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry.

P. A. Rowlings, M. M. Horowitz, J. O. Armitage, R. P. Gale, K. A. Sobocinski, M. J. Zhang, M. M. Bortin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The Statistical Center of the IBMTR/NAABMTR has expanded its role from collecting data on allogeneic and syngeneic transplants to the area of autologous bone marrow and blood cell transplantation given to support high-dose therapies for cancer. In diseases such as acute leukemia for which both allogeneic and autotransplants are performed, direct comparisons of outcomes of these therapies are now possible. The large number of cases that has accrued rapidly into the NAABMTR (over 9,000 since 1989) will allow us to use sophisticated statistical techniques to determine potential benefits and disadvantages in the rapidly growing area of autotransplantation.

Original languageEnglish (US)
Pages (from-to)101-108
Number of pages8
JournalClinical transplants
StatePublished - 1993

Fingerprint

Registries
Bone Marrow
Transplants
Autologous Transplantation
Autografts
Bone Marrow Transplantation
Blood Cells
Leukemia
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rowlings, P. A., Horowitz, M. M., Armitage, J. O., Gale, R. P., Sobocinski, K. A., Zhang, M. J., & Bortin, M. M. (1993). Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. Clinical transplants, 101-108.

Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. / Rowlings, P. A.; Horowitz, M. M.; Armitage, J. O.; Gale, R. P.; Sobocinski, K. A.; Zhang, M. J.; Bortin, M. M.

In: Clinical transplants, 1993, p. 101-108.

Research output: Contribution to journalArticle

Rowlings, P. A. ; Horowitz, M. M. ; Armitage, J. O. ; Gale, R. P. ; Sobocinski, K. A. ; Zhang, M. J. ; Bortin, M. M. / Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. In: Clinical transplants. 1993 ; pp. 101-108.
@article{4e056fea4d8c40a5abd857f1301d3d2b,
title = "Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry.",
abstract = "The Statistical Center of the IBMTR/NAABMTR has expanded its role from collecting data on allogeneic and syngeneic transplants to the area of autologous bone marrow and blood cell transplantation given to support high-dose therapies for cancer. In diseases such as acute leukemia for which both allogeneic and autotransplants are performed, direct comparisons of outcomes of these therapies are now possible. The large number of cases that has accrued rapidly into the NAABMTR (over 9,000 since 1989) will allow us to use sophisticated statistical techniques to determine potential benefits and disadvantages in the rapidly growing area of autotransplantation.",
author = "Rowlings, {P. A.} and Horowitz, {M. M.} and Armitage, {J. O.} and Gale, {R. P.} and Sobocinski, {K. A.} and Zhang, {M. J.} and Bortin, {M. M.}",
year = "1993",
language = "English (US)",
pages = "101--108",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry.

AU - Rowlings, P. A.

AU - Horowitz, M. M.

AU - Armitage, J. O.

AU - Gale, R. P.

AU - Sobocinski, K. A.

AU - Zhang, M. J.

AU - Bortin, M. M.

PY - 1993

Y1 - 1993

N2 - The Statistical Center of the IBMTR/NAABMTR has expanded its role from collecting data on allogeneic and syngeneic transplants to the area of autologous bone marrow and blood cell transplantation given to support high-dose therapies for cancer. In diseases such as acute leukemia for which both allogeneic and autotransplants are performed, direct comparisons of outcomes of these therapies are now possible. The large number of cases that has accrued rapidly into the NAABMTR (over 9,000 since 1989) will allow us to use sophisticated statistical techniques to determine potential benefits and disadvantages in the rapidly growing area of autotransplantation.

AB - The Statistical Center of the IBMTR/NAABMTR has expanded its role from collecting data on allogeneic and syngeneic transplants to the area of autologous bone marrow and blood cell transplantation given to support high-dose therapies for cancer. In diseases such as acute leukemia for which both allogeneic and autotransplants are performed, direct comparisons of outcomes of these therapies are now possible. The large number of cases that has accrued rapidly into the NAABMTR (over 9,000 since 1989) will allow us to use sophisticated statistical techniques to determine potential benefits and disadvantages in the rapidly growing area of autotransplantation.

UR - http://www.scopus.com/inward/record.url?scp=0027792006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027792006&partnerID=8YFLogxK

M3 - Article

C2 - 7918143

AN - SCOPUS:0027792006

SP - 101

EP - 108

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -